Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.
Press releases published on November 5, 2025
WorldWiDE EdTech Awards 2026 Opens Global Nominations
WELLINGTON, New Zealand, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WorldWiDE EdTech Insights today opened nominations for the 2026 edition of the WorldWiDE EdTech Awards, recognizing education technology that measurably improves learning outcomes and accessibility …
Nasdaq notification regarding minimum bid price requirement
SINGAPORE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a Singapore-based catalyst for digital transformation and Web 3.0 activation, today announced that it has received a notification …
ABS-CBN Partners with SpyCloud to Bolster Cybersecurity Defenses
AUSTIN, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SpyCloud, the leader in identity threat protection, today announced that ABS-CBN Corporation, a global storytelling company based in the Philippines, has deployed SpyCloud's identity threat protection …
DAT ALERT: AlphaTON Capital Acquires 300,000 additional TON
London, UK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON) - AlphaTON Capital, a leading investment firm focused on disruptive technologies, today announced it has acquired an additional 300,000 …
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosing In preclinical …
HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SAFFRON, a global Phase III study of ORPATHYS® ( …